Endobronchial argon plasma coagulation for treatment of hemoptysis and neoplastic airway obstruction

Citation
Rc. Morice et al., Endobronchial argon plasma coagulation for treatment of hemoptysis and neoplastic airway obstruction, CHEST, 119(3), 2001, pp. 781-787
Citations number
24
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
CHEST
ISSN journal
00123692 → ACNP
Volume
119
Issue
3
Year of publication
2001
Pages
781 - 787
Database
ISI
SICI code
0012-3692(200103)119:3<781:EAPCFT>2.0.ZU;2-K
Abstract
Study objective: To evaluate the usefulness of endobronchial argon plasma c oagulation (APC) for the treatment of hemoptysis and neoplastic airway obst ruction. Design: Retrospective study. Setting: Bronchoscopy unit of a university hospital. Patients: A total of 60 patients with bronchogenic carcinoma (n = 43), meta static tumors affecting the bronchi (n = 14), or benign bronchial disease ( n = 3). Indications for intervention were hemoptysis (n = 31), symptomatic airway obstruction (n = 14), and both obstruction and hemoptysis (n = 25), Hemoptysis was stratified as a volume of > 200 mL/d (n = 6), > 50 to 200 mL /d (n = 23), or 150 mL/d but persistence for > 1 week (n = 27). The mean (/- SD) duration of hemoptysis was 16.5 +/- 16.1 days before intervention. O bstruction sites were the trachea (n = 8), mainstem bronchi (n = 21), and l obar bronchi (n = 30), In 24 cases, the patient had obstructions at multipl e sites. The mean size of the pretreatment obstruction was 76 +/- 24.9%, Interventions: APC, a noncontact form of electrocoagulation, was performed via flexible bronchoscopy. Sixty patients underwent 70 procedures. Consciou s sedation without endotracheal intubation was used in all patients except four, who were mechanically ventilated because of underlying respiratory fa ilure. Measurements and results: All patients with hemoptysis experienced a resolu tion of bleeding immediately after APC. Hemoptysis from treated sires did n ot recur during a mean follow-up duration of 97 +/- 91.9 days. Patients wit h endoluminal airway lesions had an overall decrease in mean obstruction si ze to 18.3 +/- 22.1%. All patients with obstructive lesions, except one who died of sepsis, experienced symptom improvement. In these patients, sympto m control was maintained during a median follow-up period of 53 days (range , 18 to 321 days). There were no complications related to the procedure. Conclusions: APC is effective for the treatment of endoluminal hemoptysis a nd airway obstruction, The procedure can be performed in an outpatient sett ing or at the bedside in the ICUs. APC provides a simpler, lower-risk alter native to other interventional endobronchial techniques.